SEC Form 4 · accession 0001209191-18-059059
Audentes Therapeutics, Inc. · BOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Newman
Officer — SVP, Regulatory Affairs
Period of report
Nov 15, 2018
Accepted (ET)
Nov 16, 2018 · 6:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001628738
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2018 | A | 660 | $19.635 | A | 660 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and 16b-3(d).